article Open AccessTop 1% cited
Efficacy of azacitidine compared with that of conventional care regimens in the treatment of higher-risk myelodysplastic syndromes: a randomised, open-label, phase III study
The Lancet Oncology · 2009 · Vol. 10(3) · pp. 223–232
Pierre Fenaux✉(Université Sorbonne Paris Nord)Ghulam J. Mufti(King's College Hospital)Eva Hellström‐Lindberg(Karolinska University Hospital)Valeria Santini(Azienda Ospedaliero-Universitaria Careggi)Carlo Finelli(Istituto Oncologico Romagnolo)Aristoteles Giagounidis(St.-Johannes-Hospital Dortmund)Robert Schoch(University Hospital Schleswig-Holstein)Norbert Gattermann(Düsseldorf University Hospital)Guillermo Sanz(Hospital Universitari i Politècnic La Fe)Alan F. List(Moffitt Cancer Center)Steven D. Gore(Sidney Kimmel Comprehensive Cancer Center)John F. Seymour(Peter MacCallum Cancer Centre)John M. Bennett(University of Rochester Medical Center)John C. Byrd(The Ohio State University)Jay T. BackstromLinda ZimmermanDavid R. McKenzieC.L. BeachLewis R. Silverman(Icahn School of Medicine at Mount Sinai)
Acute Myeloid Leukemia ResearchHistone Deacetylase Inhibitors ResearchMultiple Myeloma Research and TreatmentsMedicineAzacitidineInternal medicineHazard ratioClinical endpointMyelodysplastic syndromesRandomized controlled trialInternational Prognostic Scoring SystemIntention-to-treat analysisClinical trial
MeSH terms
AdultAgedAged, 80 and overAntimetabolites, AntineoplasticAzacitidineFemaleHumansMaleMiddle AgedMyelodysplastic SyndromesProportional Hazards Models
Funding
- Celgene
Citations
2,624
FWCI
86.18
field-weighted impact
References
49
Percentile
100%
vs. same field & year
Citations per year
Cited by
Impact of TET2 mutations on response rate to azacitidine in myelodysplastic syndromes and low blast count acute myeloid leukemias
Leukemia · 2011 · 464 citations
Diagnosis and management of AML in adults: 2017 ELN recommendations from an international expert panel
Blood · 2016 · 5,802 citations
Enasidenib in mutant IDH2 relapsed or refractory acute myeloid leukemia
Blood · 2017 · 1,447 citations
Diagnosis and management of acute myeloid leukemia in adults: recommendations from an international expert panel, on behalf of the European LeukemiaNet
Blood · 2009 · 3,383 citations
A decade of exploring the cancer epigenome — biological and translational implications
Nature reviews. Cancer · 2011 · 2,835 citations
Expression of PD-L1, PD-L2, PD-1 and CTLA4 in myelodysplastic syndromes is enhanced by treatment with hypomethylating agents
Leukemia · 2013 · 675 citations
References
International Scoring System for Evaluating Prognosis in Myelodysplastic Syndromes
Blood · 1997 · 4,444 citations
Discrete sequential boundaries for clinical trials
Biometrika · 1983 · 1,735 citations
Modes of action of the DNA methyltransferase inhibitors azacytidine and decitabine
International Journal of Cancer · 2008 · 939 citations
World Health Organization Classification of Neoplastic Diseases of the Hematopoietic and Lymphoid Tissues: Report of the Clinical Advisory Committee Meeting—Airlie House, Virginia, November 1997
Journal of Clinical Oncology · 1999 · 3,285 citations
Revised Recommendations of the International Working Group for Diagnosis, Standardization of Response Criteria, Treatment Outcomes, and Reporting Standards for Therapeutic Trials in Acute Myeloid Leukemia
Journal of Clinical Oncology · 2003 · 2,650 citations
Revised Recommendations of the International Working Group for Diagnosis, Standardization of Response Criteria, Treatment Outcomes, and Reporting Standards for Therapeutic Trials in Acute Myeloid Leukemia
Journal of Clinical Oncology · 2004 · 2,141 citations
Nonparametric Estimation from Incomplete Observations
Journal of the American Statistical Association · 1958 · 7,746 citations
Regression Models and Life-Tables
Journal of the Royal Statistical Society Series B (Statistical Methodology) · 1972 · 38,926 citations
Citation Network
How this paper connects to the literature. Drag to explore, click any node to open that paper.